SCHEMBL13284094

SCHEMBL13284094

C=C1CCC(=O)N1c1cc(C(=O)OC)cc(S(N)(=O)=O)c1Sc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 1/20 0.36
▸ CA1 P00915 6/20 0.36
▸ CA2 P00918 6/20 0.36
▸ CA9 Q16790 6/20 0.36
▸ CA5A P35218 3/20 0.36
▸ PABPC1 P11940 1/20 0.35
▸ EIF4H Q15056 1/20 0.35
▸ CA4 P22748 5/20 0.35
▸ CA12 O43570 4/20 0.35
▸ CA3 P07451 4/20 0.35
▸ CA6 P23280 4/20 0.35
▸ CA7 P43166 4/20 0.35
▸ CA13 Q8N1Q1 4/20 0.35
▸ CA14 Q9ULX7 4/20 0.35
▸ CA5B Q9Y2D0 4/20 0.35
▸ ALDH1A1 P00352 4/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2880855 0.93 CA1 (0.39) ACLYCA1CA2CA9CA5A
SCHEMBL10281398 0.80 ALDH1A1 (0.51) ACLYCA1CA2CA9CA5A
SCHEMBL11640624 0.78 TUBB4A (0.34) ACLYPABPC1EIF4HALDH1A1KDM4E
SCHEMBL11540286 0.77 PABPC1 (0.36) ACLYPABPC1EIF4HALDH1A1KDM4E
SCHEMBL11549637 0.76 KDM4E (0.50) CA1CA2CA9CA5APABPC1
SCHEMBL11543053 0.74 ALDH1A1 (0.56) ACLYCA1CA2CA9CA5A
SCHEMBL16577895 0.73 PABPC1 (0.38) PABPC1EIF4HALDH1A1KDM4EHPGD
SCHEMBL11546060 0.72 L3MBTL1 (0.43) ACLYCA1CA2CA9CA5A
SCHEMBL2883320 0.72 MAPT (0.49) CA1CA2CA9CA5ACA12
SCHEMBL11543213 0.71 ALDH1A1 (0.57) ACLYCA1CA2CA9CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010085352-A2 BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2010-07-29 — — WO disclosed
Send feedback